Prostate Cancer

Substance Abuse May Worsen Advanced Prostate Cancer Outcomes

Substance Abuse May Worsen Advanced Prostate Cancer Outcomes

By

Patients with substance use disorder are more likely to be hospitalized and to make emergency department visits.

Biking Tied to PCa, But Not Reproductive Health

Biking Tied to PCa, But Not Reproductive Health

Experts note study findings aren't definitive, and risk is minimal.

Lethal Prostate Cancer Linked to Vasectomy

Lethal Prostate Cancer Linked to Vasectomy

By

Study finds a 19% increased risk of distant metastases or death from the cancer.

Depressed Men With Prostate Cancer Fare Worse

Depressed Men With Prostate Cancer Fare Worse

Those with depression, intermediate- or high-risk disease undergo less treatment.

Cranberry May Ease Radiotherapy Cystitis

Cranberry May Ease Radiotherapy Cystitis

By

Men who took cranberry capsules during and after external beam radiation treatment experienced less severe symptoms of cystitis.

Anticoagulants May Benefit Men with Advanced Prostate Cancer

Anticoagulants May Benefit Men with Advanced Prostate Cancer

By

Use of low-molecular-weight heparin decreased the risk of death by 52%.

Robotic Surgery Offers Durable Prostate Cancer Control

Robotic Surgery Offers Durable Prostate Cancer Control

By

In a study, the biochemical recurrence-free and metastasis-free survival rates were 73% and 97.5%, respectively, at 10 years.

Prostate Cancer Outcomes May Improve Under Affordable Care Act

Prostate Cancer Outcomes May Improve Under Affordable Care Act

By

Prostate cancer patients with health insurance are less likely to present with metastatic disease or die from the cancer than uninsured patients.

New Study Supports Prostate Cancer Active Surveillance

New Study Supports Prostate Cancer Active Surveillance

By

After 5 years, nearly two thirds of men remained on active surveillance.

Prostate Cancer Death Risk Tied to Age at Diagnosis

Prostate Cancer Death Risk Tied to Age at Diagnosis

By

Men aged 61 and older at diagnosis are more likely to die from the malignancy than men aged 50 or younger.

New Findings May Explain PSA Bounce

New Findings May Explain PSA Bounce

By

Transient rises in PSA after radiotherapy may be due to late damage to healthy prostatic tissue, evidence suggests.

Prostate Cancer Progression Linked to Obesity

Prostate Cancer Progression Linked to Obesity

By

Increased long-term risk observed in men on active surveillance.

Active Surveillance Underused for Low-Risk PCa

Active Surveillance Underused for Low-Risk PCa

Most physicians report that their patients are not interested in active surveillance.

High-Risk PCa More Likely to Be Diagnosed in Non-Whites

High-Risk PCa More Likely to Be Diagnosed in Non-Whites

By

Compared with whites, blacks and Hispanics have 42% and 23% increased odds, respectively, of being diagnosed with high-risk prostate cancer.

Small Prostates Predict Gleason Score Upgrading

Small Prostates Predict Gleason Score Upgrading

By

Other predictors include the presence of more than 1 positive biopsy core and a greater tumor burden.

Prostate Cancer Found in 1.4% of TURP Specimens

Prostate Cancer Found in 1.4% of TURP Specimens

By

This rate of incidental PCa detection is lower than found in previous studies.

Statin Use in Older Men Tied to Lower Physical Activity

Statin Use in Older Men Tied to Lower Physical Activity

Reasons for decline may include muscle pain, fatigue, and weakness caused by statins.

Metformin Use Decreases Risk of Prostate Cancer Diagnosis

Metformin Use Decreases Risk of Prostate Cancer Diagnosis

By

Other oral hypoglycemic agents have no effect on the risk.

Prostate Cancer Survivor Follow-Up Guidelines Developed

Prostate Cancer Survivor Follow-Up Guidelines Developed

Issues addressed include health promotion; surveillance for recurrence, new primaries.

Is a 15-year follow-up after PCa treatment reasonable?

Is a 15-year follow-up after PCa treatment reasonable?

By

A study suggests that a planned follow-up of at least 15 years after PCa treatment is reasonable.

Long-Term Testosterone Therapy Does Not Raise PCa Risk

Long-Term Testosterone Therapy Does Not Raise PCa Risk

By

Researchers report findings from a study of 942 hypogonadal men treated at 3 German centers.

Circumcision May Cut Risk of Prostate Cancer

Circumcision May Cut Risk of Prostate Cancer

Greatest protective effect observed in men circumcised at age 36 years or older.

Prostate Brachytherapy Use Decreasing

Prostate Brachytherapy Use Decreasing

By

The proportion of low-risk prostate cancer cases treated with this modality decreased by 14.3% from 2004 to 2010.

Chemo-ADT Combo Ups Survival in Patients with Metastatic PCa

Chemo-ADT Combo Ups Survival in Patients with Metastatic PCa

By

Starting docetaxel with androgen deprivation therapy prolonged median overall survival by more than 13 months versus ADT alone.

ADT May Be Safely Deferred After PSA Relapse

ADT May Be Safely Deferred After PSA Relapse

By

Immediate ADT found to offer little or no survival advantage to prostate cancer who experience biochemical recurrence.

MRI Helps Detect Significant PCa

MRI Helps Detect Significant PCa

By

It also may lower the risk of positive surgical margins in men with non-palpable tumors.

Statin Use After Prostate Cancer Surgery May Lower Recurrence Risk

Statin Use After Prostate Cancer Surgery May Lower Recurrence Risk

By

Study of 1,146 radical prostatectomy patients reveals a 36% decreased risk of PSA relapse in those who used statins after surgery.

RARP Surgical Volume Has No Effect on Quality of Life

RARP Surgical Volume Has No Effect on Quality of Life

By

Study compared surgeons who performed fewer than 100 robot-assisted radical prostatectomies with those who performed 100 or more.

Maximal Tumor Diameter Predicts PSA Failure Risk

Maximal Tumor Diameter Predicts PSA Failure Risk

By

This parameter can identify prostate cancer patients for whom adjuvant radiation therapy after radical prostatectomy may be of no benefit.

Fluoroquinolone Resistance Ups Post-Biopsy Infection Risk

Fluoroquinolone Resistance Ups Post-Biopsy Infection Risk

By

Detecting fluoroquinolone-resistant organisms may allow for targeted antibiotic prophylaxis and identification of men at risk for infection.

Sign Up for Free e-newsletters